Clinical Trial Update: Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma [NA]

View source ↗

Summary

The clinical trial evaluating PET imaging with FDG-18 to predict response in newly diagnosed Non-Hodgkin lymphoma patients treated with rituximab and chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lymphoma | NA | Status: WITHDRAWN